High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Archives of Toxicology

• Publication date

  2006-04-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00204-006-0091-3PMID 16598496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comprehensive listing of bioactivation pathways of organic functional groups.

  2005influential reference
• Editorial [Hot Topic: Clinical Investigations (Endothelial Function and Thrombosis), Intracellular Metabolism and Cell Culture Studies with Infectious Agents (Guest Editor: Olaf Stanger)]

  2005cited by this paper
• Idiosyncratic drug hepatotoxicity

  2005influential reference
• Cytotoxic effects of 110 reference compounds on HepG2 cells and for 60 compounds on HeLa, ECC-1 and CHO cells. II mechanistic assays on NAD(P)H, ATP and DNA contents.

  2005cited by this paper
• Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake.

  2005cited by this paper
• Causality assessment in drug-induced hepatotoxicity

  2004cited by this paper
• Liver transplantation for acute liver failure from drug induced liver injury in the United States

  2004cited by this paper
• Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential.

  2004influential reference
• High content screening applied to large-scale cell biology.

  2004cited by this paper
• Mitochondrial toxicity of nrti antiviral drugs: an integrated cellular perspective

  2003cited by this paper
• Drug-induced liver disease.

  2003cited by this paper
• Advances in High Content Screening for Drug Discovery

  2003influential reference
• Idiosyncratic Drug Hepatotoxicity Revisited: New Insights from Mechanistic Toxicology

  2003cited by this paper
• Drug-induced hepatotoxicity.

  2003cited by this paper
• Disease-related determinants of susceptibility to drug-induced idiosyncratic hepatotoxicity.

  2003cited by this paper
• Drug-induced liver disease

  2002cited by this paper
• Mechanisms of hepatotoxicity.

  2002cited by this paper
• Applications of hormesis in toxicology, risk assessment and chemotherapeutics.

  2002cited by this paper
• Effect of diquat on the antioxidant system and cell growth in human neuroblastoma cells.

  2002cited by this paper
• Drug-Induced Liver Disorders

  2001cited by this paper
• A mitochondrial perspective on cell death.

  2001cited by this paper
• Hormesis - A Pharmaceutical Industry Perspective

  2001cited by this paper
• Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes

  2001cited by this paper
• Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999

  2001cited by this paper
• A Strategy for Primary High Throughput Cytotoxicity Screening in Pharmaceutical Toxicology

  2000cited by this paper
• Concordance of the toxicity of pharmaceuticals in humans and in animals.

  2000influential reference
• Monitoring simultaneous subcellular events in vitro by means of coherent multiprobe fluorescence

  1999cited by this paper
• A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity.

  1998cited by this paper
• The predictivity of the toxicity of pharmaceuticals in humans from animal data--an interim assessment.

  1998cited by this paper
• Fluorometric and colorimetric detection of caspase activity associated with apoptosis.

  1997cited by this paper
• Improved fluorescent bioassay for the detection of tumor necrosis factor activity.

  1995cited by this paper
• Drug-induced hepatotoxicity.

  1995cited by this paper
• Kinetic analysis of glutathione in anchored cells with monochlorobimane.

  1995cited by this paper
• Compensatory increase in calcium extrusion activity of untreated lymphocytes from swine susceptible to malignant hyperthermia.

  1990cited by this paper
• An equation to describe dose responses where there is stimulation of growth at low doses

  1989cited by this paper
• Porcine malignant hyperthermia susceptibility: halothane-induced increase in cytoplasmic free calcium in lymphocytes.

  1989cited by this paper
• Gentisic acid: an aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes.

  1986cited by this paper
• Drug induced liver disease.

  1983cited by this paper
• INHIBITION OF PROTEIN SYNTHESIS BY CYCLOHEXIMIDE IN RABBIT RETICULOCYTES.

  1965cited by this paper
• The replication of DNA.

  1958cited by this paper

• Rat and human primary proximal tubule epithelial cells allow for cross-species comparisons of drug-induced nephrotoxicity in vitro.

  2026cites this paper
• Drug-induced cytotoxicity prediction in muscle cells, an application of the Cell Painting assay

  2025cites this paper
• PKSmart: an open-source computational model to predict intravenous pharmacokinetics of small molecules

  2025cites this paper
• Translational regulation of SND1 governs endothelial homeostasis during stress

  2025cites this paper
• Exploration of Fluorinated Peptoid‐Based Histone Deacetylase Inhibitors as Dual‐Stage Antiplasmodial Agents

  2025cites this paper
• A large-scale human toxicogenomics resource for drug-induced liver injury prediction

  2025cites this paper
• Investigating the Possible Human Health Risks Associated with Bioallethrin

  2025cites this paper
• Morphological profiling data resource enables prediction of chemical compound properties

  2025cites this paper
• New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?

  2025cites this paper
• In vitro cytotoxic, genotoxic, and multi-parameter hepatotoxic evaluation of selected South African medicinal plant extracts

  2025cites this paper
• Integration of In Vitro and In Silico Approaches Enables Prediction of Drug-Induced Liver Injury

  2025cites this paper
• Leveraging multi-organ models for drug combination therapy safety.

  2025cites this paper
• Morphological Profiling Dataset of EU-OPENSCREEN Bioactive Compounds Over Multiple Imaging Sites and Cell Lines

  2024cites this paper
• Combined use of multiparametric high-content-screening and in vitro circadian reporter assays in neurotoxicity evaluation

  2024cites this paper
• Association of Di(2-ethylhexyl) Terephthalate and Its Metabolites with Nonalcoholic Fatty Liver Disease: An Epidemiology and Toxicology Study.

  2024cites this paper
• Control Compounds for Preclinical Drug-Induced Liver Injury Assessment: Consensus-driven systematic review by the ProEuroDILI Network.

  2024cites this paper
• A novel in vitro high-content imaging assay for the prediction of drug-induced lung toxicity

  2024cites this paper
• Comparison of in vitro models for drug-induced liver injury assessment

  2024cites this paper
• Investigation of the anticancer effect of newly synthesized palladium conjugate Schiff base metal complexes on non-small cell lung cancer cell line and mouse embryonic fibroblast cell line.

  2024cites this paper
• Liver organoids: updates on generation strategies and biomedical applications

  2024cites this paper
• Physiological liver microtissue 384-well microplate system for preclinical hepatotoxicity assessment of therapeutic small molecule drugs

  2024cites this paper
• Prediction of Drug‐Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches

  2024cites this paper
• In Vitro Hepatotoxicity of Routinely Used Opioids and Sedative Drugs

  2024cites this paper
• Hepatoprotective potential of Coconut Inflorescence Sap against Paracetamol induced toxicity in Hep G2 cell lines.

  2024cites this paper
• Impacts of small-molecule STAT3 inhibitor SC-43 on toxicity, global proteomics and metabolomics of HepG2 cells.

  2024cites this paper
• A network-based transcriptomic landscape of HepG2 cells uncovering causal gene-cytotoxicity interactions underlying drug-induced liver injury

  2023cites this paper
• Alternative Methods in Science: Towards Fluidic Systems.

  2023cites this paper
• Anti-Trypanosoma cruzi Activity, Mutagenicity, Hepatocytotoxicity and Nitroreductase Enzyme Evaluation of 3-Nitrotriazole, 2-Nitroimidazole and Triazole Derivatives

  2023cites this paper
• A flexible, image-based, high-throughput platform encompassing in-depth cell profiling to identify broad-spectrum coronavirus antivirals with limited off-target effects.

  2023cites this paper
• High-content analysis of testicular toxicity of BPA and its selected analogs in mouse spermatogonial, Sertoli cells, and Leydig cells revealed BPAF induced unique multinucleation phenotype associated with the increased DNA synthesis.

  2023cites this paper
• The Precision Toxicology Initiative.

  2023cites this paper
• GeoDILI: A Robust and Interpretable Model for Drug-Induced Liver Injury Prediction Using Graph Neural Network-Based Molecular Geometric Representation.

  2023cites this paper
• Enhancement of the Cytotoxicity of Quinazolinone Schiff Base Derivatives with Copper Coordination

  2023cites this paper
• A Review of Reagents for Fluorescence Microscopy of Cellular Compartments and Structures, Part II: Reagents for Non‐Vesicular Organelles

  2023cites this paper
• Impact of Exposure to Pyraclostrobin and to a Pyraclostrobin/Boscalid Mixture on the Mitochondrial Function of Human Hepatocytes

  2023cites this paper
• In Vitro Assessment of Drug-Induced Liver Injury Using Cell-Based Models: A Review

  2023cites this paper
• A Network-based Transcriptomic Landscape of HepG2 cells to Uncover Causal Gene Cytotoxicity Interactions Underlying Drug-Induced Liver Injury

  2023cites this paper
• Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor.

  2023cites this paper
• Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen

  2023cites this paper
• Evaluation of in vitro hepatotoxicity of perampanel in comparison with carbamazepine: old versus new

  2023cites this paper
• Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives

  2023cites this paper
• Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation

  2022cites this paper
• Dephospho-Coenzyme A Kinase Is an Exploitable Drug Target against Plasmodium falciparum: Identification of Selective Inhibitors by High-Throughput Screening of a Large Chemical Compound Library

  2022cites this paper
• Occurrence and Cytotoxicity of Aliphatic and Aromatic Halogenated Disinfection Byproducts in Indoor Swimming Pool Water and Their Incoming Tap Water.

  2022cites this paper
• In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation

  2022influential citation
• Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

  2022cites this paper
• Rational deuteration of dronedarone attenuates its toxicity in human hepatic HepG2 cells.

  2022cites this paper
• Protein Hydrolysates from Brewing By-Products as Natural Alternatives to ACE-Inhibitory Drugs for Hypertension Management

  2022cites this paper
• Developing an artificial intelligence method for screening hepatotoxic compounds in traditional Chinese medicine and Western medicine combination

  2022cites this paper
• An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model

  2022cites this paper
• Modeling drug-induced liver injury: current status and future prospects

  2022cites this paper
• Toxicity of pesticides widely applied on soybean cultivation: Synergistic effects of fipronil, glyphosate and imidacloprid in HepG2 cells.

  2022cites this paper
• Assessing Drug-Induced Mitochondrial Toxicity in Cardiomyocytes: Implications for Preclinical Cardiac Safety Evaluation

  2022cites this paper
• A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds.

  2022cites this paper
• UV-B filter octylmethoxycinnamate-induced vascular endothelial disruption on rat aorta: In silico and in vitro approach.

  2022cites this paper
• Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials

  2022cites this paper
• Early Drug-Induced Liver Injury (DILI) Risk Screening: "Free", as good as it gets.

  2022cites this paper
• Oxidative-stress and long-term hepatotoxicity: comparative study in Upcyte human hepatocytes and hepaRG cells

  2022cites this paper
• The prediction approach of drug-induced liver injury: response to the issues of reproducible science of artificial intelligence in real-world applications

  2022cites this paper
• In Silico Models for Hepatotoxicity.

  2022cites this paper
• Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury.

  2021cites this paper
• Computational design of new tacrine analogs: an in silico prediction of their cholinesterase inhibitory, antioxidant, and hepatotoxic activities

  2021cites this paper
• Computational Approaches for Drug-Induced Liver Injury (DILI) Prediction: State of the Art and Challenges

  2021cites this paper
• Combining in vitro assays and mathematical modelling to study developmental neurotoxicity induced by chemical mixtures

  2021cites this paper
• JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical Candidate.

  2021cites this paper
• The Short-Term Exposure to SDHI Fungicides Boscalid and Bixafen Induces a Mitochondrial Dysfunction in Selective Human Cell Lines

  2021cites this paper
• Nickel oxide nanoparticles induced DNA damages in human liver cells

  2021cites this paper
• The in vitro assessment of the toxicity of volatile, oxidisable, redox-cycling compounds: phenols as an example

  2021cites this paper
• Therapeutic effects and potential mechanism of dehydroevodiamine on N-methyl-N'-nitro-N-nitrosoguanidine-induced chronic atrophic gastritis.

  2021cites this paper
• In VITRO biochemical characterization and genotoxicity assessment of Sapindus saponaria seed extract.

  2021cites this paper
• Integration of temporal single cell cellular stress response activity with Logic-ODE modeling reveals activation of ATF4-CHOP axis as a critical predictor of drug-induced liver injury.

  2021cites this paper
• Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism

  2021cites this paper
• Oleanolic Acid Induces Autophagy and Apoptosis via the AMPK-mTOR Signaling Pathway in Colon Cancer

  2021cites this paper
• Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity

  2021cites this paper
• Ursolic Acid Regulates Cell Cycle and Proliferation in Colon Adenocarcinoma by Suppressing Cyclin B1

  2021cites this paper
• Comparison of Cellular Morphological Descriptors and Molecular Fingerprints for the Prediction of Cytotoxicity- and Proliferation-Related Assays.

  2021cites this paper
• Zuojin Pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/Akt axis.

  2021cites this paper
• High-Content Screening for the Detection of Drug-Induced Oxidative Stress in Liver Cells

  2021cites this paper
• Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity.

  2021cites this paper
• Qualifying a human Liver-Chip for predictive toxicology: Performance assessment and economic implications

  2021cites this paper
• Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury.

  2021cites this paper
• The Promise of AI for DILI Prediction

  2021cites this paper
• Five Constituents Contributed to the Psoraleae Fructus-Induced Hepatotoxicity via Mitochondrial Dysfunction and Apoptosis

  2021cites this paper
• Induced pluripotent stem cells in liver disease

  2021cites this paper
• Estimating Hepatotoxic Doses Using High-Content Imaging in Primary Hepatocytes.

  2021cites this paper
• Quantitative evaluation of explainable graph neural networks for molecular property prediction

  2021cites this paper
• A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies

  2021influential citation
• [From high content screening to target deconvolution: New insights for phenotypic approaches].

  2021cites this paper
• Human Drug Metabolism

  2020cites this paper
• Mitochondrial dysfunction and apoptosis underlie the hepatotoxicity of perhexiline.

  2020cites this paper
• [Recent advances in evaluation studies for drug-induced liver injury].

  2020cites this paper
• Drugs

  2020cites this paper
• Predicting Chemical-induced Liver Toxicity Using High Content Imaging Phenotypes and Chemical Descriptors: A Random Forest Approach.

  2020cites this paper
• Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR.

  2020cites this paper
• Optimum concentration–response curve metrics for supervised selection of discriminative cellular phenotypic endpoints for chemical hazard assessment

  2020cites this paper
• An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury

  2020cites this paper
• Models of Idiosyncratic Drug-Induced Liver Injury.

  2020cites this paper
• Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery

  2020cites this paper
• A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C10).

  2020cites this paper
• Predicting direct hepatocyte toxicity in humans by combining high-throughput imaging of HepaRG cells and machine learning-based phenotypic profiling

  2020cites this paper